• 主题
高级搜索  >
历史搜索 清空历史
首页> 外文期刊>Oftal mokhirurgiya >ОПЫТ КЛИНИЧЕСКОГО ПРИМЕНЕНИЯ ПЕРЕДНЕКАМЕРНОЙ ФАКИЧНОЙ ИОЛ ACRYSOF CACHET ДЛЯ ХИРУРГИЧЕСКОЙ КОРРЕКЦИИ МИОПИИ ВЫСОКОЙ СТЕПЕНИ
【24h】

ОПЫТ КЛИНИЧЕСКОГО ПРИМЕНЕНИЯ ПЕРЕДНЕКАМЕРНОЙ ФАКИЧНОЙ ИОЛ ACRYSOF CACHET ДЛЯ ХИРУРГИЧЕСКОЙ КОРРЕКЦИИ МИОПИИ ВЫСОКОЙ СТЕПЕНИ

机译：面神经纤维晶状体囊切除术矫正高度近视的临床应用经验

获取原文
           
页面导航
  • 摘要
  • 著录项
  • 相似文献
  • 相关主题

摘要

Purpose. To study the clinical results of angle-supported phakic intraocular lenses (pIOL) implantations in patients with high myopia. Material and methods. The study group included 16 patients (32 eyes) aged 25±5 years (from 21 to 36 years) with high myopia – 13.33±2.82D (from -8.25 to -18.25D), where excimer laser refractive procedures were not indicated due to the thin cornea pachymetry readings and/or high predicted residual refractive error. The conventional examinations were performed preoperatively and in different postoperative periods (follow-up: up to 1 year). The preoperative best corrected visual acuity (BCVA) was 0.68±0.18 (within the range from 0.3 to 1.0). In addition to the standard examinations, special diagnostic techniques were carried out including: keratotopography, pupillometry, anterior segment OCT, endothelial microscopy using the confocal microscope. Results. All surgeries were uneventful. On the first postoperative day, the uncorrected visual acuity (UCVA) from 0.90 to 1.00 was noted in 88% of cases, the UCVA higher than 0.6 – in 94%. The average spherical error postoperatively was -0.54±0.56D (range from 0.00 to -1.25D) and remained stable throughout the entire follow-up. The endothelial cell loss 1 year after the surgery was equal to 3.25%. All patients were satisfied with the results of treatment. Conclusion. Implantation of anterior chamber angle-supported pIOL Acrysof Cachet in patients with a high myopia considered to be safe, effective, and providing rapid visual rehabilitation.
机译：目的。研究高度近视患者角度支持的晶状体人工晶状体（pIOL）植入的临床结果。材料与方法。研究组包括16位（32眼）年龄25±5岁（21至36岁）的高度近视– 13.33±2.82D（从-8.25至-18.25D），其中由于以下原因未标明准分子激光屈光手术：薄的角膜测厚仪读数和/或预计的高残留屈光不正。常规检查在术前和术后不同时期进行（随访：长达1年）。术前最佳矫正视力（BCVA）为0.68±0.18（范围从0.3到1.0）。除标准检查外，还进行了特殊的诊断技术，包括：角膜地形图，瞳孔测定，OCT前段，共聚焦显微镜的内皮镜检查。结果。所有手术都很顺利。术后第一天，在88％的病例中观察到未矫正的视力（UCVA）从0.90到1.00，UCVA高于0.6 – 94％。术后平均球面误差为-0.54±0.56D（范围从0.00至-1.25D），并在整个随访过程中保持稳定。手术后一年的内皮细胞损失等于3.25％。所有患者对治疗结果均满意。结论。高度近视患者前房角支持pIOL Acrysof Cachet的植入被认为是安全，有效并能快速恢复视力。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

  • 客服微信

  • 服务号